{"id":22746,"date":"2021-05-10T16:57:06","date_gmt":"2021-05-10T14:57:06","guid":{"rendered":"https:\/\/kymos.com\/news\/casos-reals-de-pharmaprogress-a-la-taula-rodona-del-simposi-aefi-sobre-nitrosamines\/"},"modified":"2025-08-07T09:43:22","modified_gmt":"2025-08-07T07:43:22","slug":"casos-reals-de-pharmaprogress-a-la-taula-rodona-del-simposi-aefi-sobre-nitrosamines","status":"publish","type":"post","link":"https:\/\/kymos.com\/ca\/news\/casos-reals-de-pharmaprogress-a-la-taula-rodona-del-simposi-aefi-sobre-nitrosamines\/","title":{"rendered":"Casos reals de Pharmaprogress a la taula rodona del simposi AEFI sobre nitrosamines"},"content":{"rendered":"

Pharmaprogress\u2019 real-life cases in AEFI symposium Round Table on Nitrosamines<\/h3>\n
\n
\n
\n
\n

Luca Gramaccioni, Site General Manger at Kymos Pharmaprogress<\/a>, was a guest speaker at the 40th AEFI symposium last May 11th. He presented \u201cNitrosamines: How to face the analytical challenges for step 2\u201d at a Round Table alongside other experts from AEMPs, AZIERTA and AGILENT.
\nIn his presentation Dr. Gramaccioni evaluated the advantages of outsourcing non-routine testing of N-nitrosamine impurities, data requirements from regulatory authorities and showed three real-life case studies taken from daily practice.
\nCheck out this video to learn more about Luca Gramaccioni\u2019s first-hand experience with Nitrosamines.<\/p>\n

\n
\n

Real-life Nitrosamine cases at the AEFI Symposium Round Table<\/a><\/h2>\n<\/div>\n<\/div>\n

\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>

\n\n Please \n\n accept marketing-cookies<\/a> \n\n to watch this video.\n
\n\t<\/a>\n\n<\/div>\n